Mo-99 Manufacturing Facility
ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.
Showing 121 - 140 of 537 results
ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.
In partnership with the Australian Museum as part of National Science Week explore the 2020 hackathon theme of Deep Blue: Innovation for the future of our oceans
ANSTO has a full suite of mineralogical, chemical and hydrometallurgical facilities from laboratory through to pilot scale.
Since the discovery of superconducting Caintercalated graphite (CaC6) the intercalation of epitaxial graphene on SiC(0001) with Ca has been studied extensively in order to achieve superconductivity.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.
A lift for fish at Tallowa Dam: Study on dietary impacts.
Using the theory of compressed sensing technology, a team of physicists and scientists invented and developed the CORIS360® platform imaging technology. Compressed sensing imaging can generate an image with far fewer samples compared with traditional imaging techniques.
Within the bulk structure of such glasses, boron is known to be a key actor, as it exhibits intriguing and composition-dependent changes in coordination state that often drive properties.
In accordance with the Trust Deed, the United Uranium Scholarship is awarded to ‘promising young scientists’ from any Australian organisation or institution whose research or work is in the field of nuclear energy.
Ongoing media statements relating to nuclear medicine production.
Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,
ANSTO operates a range of cobalt-60 gamma irradiators, providing the Australian community with a range of irradiation services for medical, health, industry, agriculture and research purposes.
A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.
Below lists some useful programs for data reduction, search matching, analysis and structure visualisation of diffraction data.
Collaboration across the Tasman has enabled Australian and New Zealand researchers and scientists to shed light on a protein involved in diseases such as Parkinson’s disease, gastric cancer and melanoma.
New high energy ion microprobe beamline supports space research on the effects of radiation on astronauts.
In Australia and the Southeast Asia basin, the ANSTO facility offers a wide range of unique nuclear-beam techniques for cultural heritage research.